INS and type 1 diabetes mellitus: The ex vivo hepatocyte transduction and transplantation of insulin producing cells for T1DM treatment is more complex but has the advantage of making it possible to pretest insulin-producing cells to optimize the treatment, and minimize the systemic exposure of TA1m to the recipient.